Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
Clinical trial NCT01298076 · COMPLETED
Trial details
- NCT number
- NCT01298076
- Sponsor
- University of Sydney
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2014-09-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.